$CHRD

Mizuho raises Chord Energy stock price target to $179 on asset sale

Mizuho raised its price target for Chord Energy (NASDAQ:CHRD) to $179 from $175, maintaining an Outperform rating. The company's stock is trading at $137.01, with a low P/E ratio of 9.3 and a financial health score of 3.18. The upgrade follows the sale of nonoperated Marcellus assets, which generated proceeds 40% above Mizuho's estimate. Chord Energy's Q2 2026 earnings missed expectations, but the company highlighted strong free cash flow and shareholder returns.

Original reporting
Published Oct 5, 2026, 10:02 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 10:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CHRD
Bullish
high confidence
Mentioned
$CHRD
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CHRDBullishMed
01

Why it matters

The combination of a sizable asset divestiture and higher price targets creates a fresh bullish catalyst for CHRD.

02

Market read

New valuation and balance‑sheet improvement could drive short‑term buying interest in CHRD.

03

What to watch

Potential tax or integration costs from the sale and the long‑term impact on production volumes.

Relevance 8/10Novelty 7/10Timing: pre‑market today

Background

Chord Energy reported Q2 earnings that missed estimates, but the subsequent Marcellus asset sale and analyst target upgrades provide new material.

Company-level read

Ticker impact

$CHRDBullishHigh confidence
Context

Mizuho raised its price target on Chord Energy to $179 and highlighted a $550 million Marcellus asset sale, providing fresh valuation and balance‑sheet impact.

Expected impact

likely upward pressure as investors price in the stronger balance sheet and higher target.

Evidence & confidence

A $550 M sale is material for a mid‑cap energy producer and the new $179 target is above current price, indicating a bullish catalyst.

Market effects

May lift peer U.S. mid‑cap energy stocks as the sale signals consolidation in the Marcellus region.

Limited to U.S. energy sector, no broader regional effect.

Low; impact confined to CHRD and its immediate peers.

Counterpoint

The asset sale could signal a need for cash, hinting at underlying operational challenges.

Key entities

  • Mizuho

    Raised price target to $179.

  • Truist Securities

    Raised price target to $180.

  • UBS

    Adjusted price target to $184.

Related articles

$CHRDMed

Chord Energy (CHRD) Gets a Buy from BMO Capital

BMO Capital analyst Phillip Jungwirth maintained a Buy rating on Chord Energy (CHRD) with a $160 price target. Chord reported Q2 revenue of $2.17B and net profit of $525.19M, up from last year's $1.18B revenue and net loss of $389.91M. Insider sentiment is negative, with recent sales by directors.

$CHRDMedAI 8/10

Chord Energy (CHRD), What Is Behind The Fresh Attention On The Stock?

Chord Energy (CHRD) agreed to sell a $550M Marcellus position to POSCO International, focusing on Williston Basin assets. The stock has seen mixed performance, down 4.95% in the past week but up 52.61% year-to-date. Analysts suggest the stock is undervalued, with a fair value estimate of $167.47, citing strong drilling performance and potential for increased margins.

$CHRDMed

Chord Energy price target raised to $180 from $166 at Truist

Truist analyst Gabe Daoud raised Chord Energy's (CHRD) price target to $180 from $166, maintaining a Buy rating. This follows Chord's $550M divestiture of its Marcellus position. Truist believes this deal's valuation metrics could benefit Devon (DVN) if it sells its NEPA asset, implying about $9B in value.